KGC Unveils Premium Ingredient Brand 'G1899' for Global B2B Market

Korea Ginseng Corporation (KGC), a prominent name in global health and wellness, has recently expanded its horizons by introducing a new standardized premium ingredient brand known as "G1899". This launch marks a significant entry into the bustling global B2B health ingredient market and aims to serve partners with high-quality natural ingredients derived from the company’s rich heritage.

The Significance of 'G1899'

The name "G1899" is deeply rooted in KGC’s history, symbolizing the company’s legacy that dates back to 1899, the year it began cultivating ginseng. This brand is not just a new name but represents KGC's commitment to providing a diverse range of standardized natural ingredients while also extending its influence from red ginseng to various other offerings in the health sector.

In light of the increasing global demand for premium, natural, and functional health components, KGC emphasizes the unique benefits of red ginseng. As a non-GMO and gluten-free ingredient, red ginseng aligns well with contemporary wellness trends and has been scientifically validated for multiple health benefits, recognized by the Korean Ministry of Food and Drug Safety. With over 1,200 research papers supporting its efficacy, red ginseng serves as the foundation for G1899.

Global Debut at SSG 2025

KGC proudly showcased G1899 at the SupplySide Global 2025 (SSG 2025) in Las Vegas, one of the largest ingredient exhibitions worldwide. The event provided a platform for KGC to connect with major food and supplement companies, demonstrating the scientific excellence behind their red ginseng ingredients. Additionally, KGC shared rigorous quality control processes and innovative formulation techniques that confirm red ginseng's superior quality.

Attendees were introduced to KGC's comprehensive contract cultivation systems, details on international certifications achieved, and exciting formulations for various applications such as health beverages in liquid, powder, capsule, tablet, and gummy forms. A significant highlight was a series of tasting sessions featuring health beverages infused with red ginseng extract, which drew considerable attention and enthusiasm from the audience.

Emphasizing Quality and Research

KGC’s manufacturing process stands out for its dedication to quality assurance and consistency. By implementing a contract cultivation strategy with local farmers, KGC manages every stage from soil quality before planting to the growth of ginseng, applying over 430 safety tests to each batch produced. The company’s production facilities boast stringent certifications including HACCP and FSSC 22000, showcasing KGC's commitment to pharmaceutical-grade hygiene and quality management.

Furthermore, KGC's Research and Development Center plays a pivotal role in maintaining innovation throughout the entire value chain, from ingredient development to product formulation. With over 320 patents and more than 350 academic publications, KGC's efforts have not gone unnoticed, as the firm has been awarded the esteemed Varro E. Tyler Award, recognizing their leadership in the botanicals sector.

Commitment to Global Presence

KGC's launch of G1899 signals not only its ambition to lead in the B2B health ingredient sector but also reflects its broader strategy to collaborate with international partners. As KGC continues to explore markets beyond its well-recognized brand JungKwanJang, the company is poised to maintain its status as the global leader in both ginseng retail and herbal supplements, a position it has held for 11 consecutive years according to Euromonitor International.

In conclusion, with the introduction of G1899, KGC is set to further enhance its international competitiveness, bringing the excellence of its ingredients and health benefits to consumers around the globe. This move not only reinforces KGC’s heritage but also fosters a future built on innovation and collaboration in the health and wellness industry.